Brightcom Group Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 16, 2025, 8:35 am

Quick Insight

Brightcom Group Ltd, operating in the IT consulting and software industry, currently trades at a price of 14.6 with a market capitalization of ₹2,936 Cr. The company's low P/E ratio of 4.14 suggests undervaluation, while ROE stands at 8.62% and ROCE at 12.3%, indicating decent profitability and capital efficiency. With a high OPM of 26% and robust net profit of ₹710 Cr, Brightcom shows strong operational performance. Additionally, the company's healthy reserves of ₹8,286 Cr and absence of borrowings reflect a strong financial position. The significant promoter holding of 18.38% instills confidence, although FII and DII holdings are relatively low. The stock's low P/BV ratio of 0.42x could indicate further room for upside potential. In conclusion, Brightcom Group Ltd appears fundamentally sound and could be an attractive investment opportunity for those seeking undervalued stocks in the IT sector.

Competitors of Brightcom Group Ltd

All Competitor Stocks of Brightcom Group Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:05 pm

Below is a detailed analysis of the quarterly data for Brightcom Group Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 987.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,674.00 Cr. (Dec 2024) to 987.00 Cr., marking a decrease of 687.00 Cr..
• For Expenses, as of Mar 2025, the value is 731.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,247.00 Cr. (Dec 2024) to 731.00 Cr., marking a decrease of 516.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 256.00 Cr.. The value appears to be declining and may need further review. It has decreased from 427.00 Cr. (Dec 2024) to 256.00 Cr., marking a decrease of 171.00 Cr..
• For OPM %, as of Mar 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 26.00%.
• For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 82.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 76.00 Cr. (Dec 2024) to 82.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 174.00 Cr.. The value appears to be declining and may need further review. It has decreased from 351.00 Cr. (Dec 2024) to 174.00 Cr., marking a decrease of 177.00 Cr..
• For Tax %, as of Mar 2025, the value is 31.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 31.00%.
• For Net Profit, as of Mar 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 244.00 Cr. (Dec 2024) to 121.00 Cr., marking a decrease of 123.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 0.60. The value appears to be declining and may need further review. It has decreased from 1.21 (Dec 2024) to 0.60, marking a decrease of 0.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:53 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:20 pm

Below is a detailed analysis of the balance sheet data for Brightcom Group Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 404.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 404.00 Cr..
• For Reserves, as of Mar 2025, the value is 8,286.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,381.00 Cr. (Mar 2024) to 8,286.00 Cr., marking an increase of 905.00 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,111.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 977.00 Cr. (Mar 2024) to 1,111.00 Cr., marking an increase of 134.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 9,800.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,762.00 Cr. (Mar 2024) to 9,800.00 Cr., marking an increase of 1,038.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,171.00 Cr.. The value appears strong and on an upward trend. It has increased from 851.00 Cr. (Mar 2024) to 1,171.00 Cr., marking an increase of 320.00 Cr..
• For CWIP, as of Mar 2025, the value is 182.00 Cr.. The value appears to be declining and may need further review. It has decreased from 400.00 Cr. (Mar 2024) to 182.00 Cr., marking a decrease of 218.00 Cr..
• For Investments, as of Mar 2025, the value is 583.00 Cr.. The value appears strong and on an upward trend. It has increased from 572.00 Cr. (Mar 2024) to 583.00 Cr., marking an increase of 11.00 Cr..
• For Other Assets, as of Mar 2025, the value is 7,864.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,939.00 Cr. (Mar 2024) to 7,864.00 Cr., marking an increase of 925.00 Cr..
• For Total Assets, as of Mar 2025, the value is 9,800.00 Cr.. The value appears strong and on an upward trend. It has increased from 8,762.00 Cr. (Mar 2024) to 9,800.00 Cr., marking an increase of 1,038.00 Cr..

Notably, the Reserves (8,286.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Brightcom Group Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 23, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 23, the value is 6.79. This value is within the healthy range. It has increased from 4.52 (Mar 22) to 6.79, marking an increase of 2.27.
• For Diluted EPS (Rs.), as of Mar 23, the value is 6.79. This value is within the healthy range. It has increased from 4.52 (Mar 22) to 6.79, marking an increase of 2.27.
• For Cash EPS (Rs.), as of Mar 23, the value is 8.11. This value is within the healthy range. It has increased from 5.74 (Mar 22) to 8.11, marking an increase of 2.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 34.68. It has increased from 26.24 (Mar 22) to 34.68, marking an increase of 8.44.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 34.68. It has increased from 26.24 (Mar 22) to 34.68, marking an increase of 8.44.
• For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 36.64. It has increased from 24.88 (Mar 22) to 36.64, marking an increase of 11.76.
• For PBDIT / Share (Rs.), as of Mar 23, the value is 10.73. This value is within the healthy range. It has increased from 7.46 (Mar 22) to 10.73, marking an increase of 3.27.
• For PBIT / Share (Rs.), as of Mar 23, the value is 9.42. This value is within the healthy range. It has increased from 6.24 (Mar 22) to 9.42, marking an increase of 3.18.
• For PBT / Share (Rs.), as of Mar 23, the value is 9.41. This value is within the healthy range. It has increased from 6.23 (Mar 22) to 9.41, marking an increase of 3.18.
• For Net Profit / Share (Rs.), as of Mar 23, the value is 6.79. This value is within the healthy range. It has increased from 4.52 (Mar 22) to 6.79, marking an increase of 2.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 6.79. This value is within the healthy range. It has increased from 4.52 (Mar 22) to 6.79, marking an increase of 2.27.
• For PBDIT Margin (%), as of Mar 23, the value is 29.28. This value is within the healthy range. It has decreased from 29.97 (Mar 22) to 29.28, marking a decrease of 0.69.
• For PBIT Margin (%), as of Mar 23, the value is 25.69. This value exceeds the healthy maximum of 20. It has increased from 25.07 (Mar 22) to 25.69, marking an increase of 0.62.
• For PBT Margin (%), as of Mar 23, the value is 25.68. This value is within the healthy range. It has increased from 25.06 (Mar 22) to 25.68, marking an increase of 0.62.
• For Net Profit Margin (%), as of Mar 23, the value is 18.53. This value exceeds the healthy maximum of 10. It has increased from 18.17 (Mar 22) to 18.53, marking an increase of 0.36.
• For NP After MI And SOA Margin (%), as of Mar 23, the value is 18.53. This value is within the healthy range. It has increased from 18.17 (Mar 22) to 18.53, marking an increase of 0.36.
• For Return on Networth / Equity (%), as of Mar 23, the value is 19.58. This value is within the healthy range. It has increased from 17.22 (Mar 22) to 19.58, marking an increase of 2.36.
• For Return on Capital Employeed (%), as of Mar 23, the value is 27.09. This value is within the healthy range. It has increased from 23.70 (Mar 22) to 27.09, marking an increase of 3.39.
• For Return On Assets (%), as of Mar 23, the value is 17.36. This value is within the healthy range. It has increased from 15.35 (Mar 22) to 17.36, marking an increase of 2.01.
• For Total Debt / Equity (X), as of Mar 23, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 23, the value is 1.07. It has increased from 0.13 (Mar 22) to 1.07, marking an increase of 0.94.
• For Current Ratio (X), as of Mar 23, the value is 6.87. This value exceeds the healthy maximum of 3. It has increased from 6.69 (Mar 22) to 6.87, marking an increase of 0.18.
• For Quick Ratio (X), as of Mar 23, the value is 6.87. This value exceeds the healthy maximum of 2. It has increased from 6.69 (Mar 22) to 6.87, marking an increase of 0.18.
• For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.57 (Mar 22) to 0.00, marking a decrease of 0.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 0.44 (Mar 22) to 0.00, marking a decrease of 0.44.
• For Earning Retention Ratio (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.43 (Mar 22) to 0.00, marking a decrease of 99.43.
• For Cash Earning Retention Ratio (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 99.56 (Mar 22) to 0.00, marking a decrease of 99.56.
• For Interest Coverage Ratio (X), as of Mar 23, the value is 5,285.70. This value is within the healthy range. It has increased from 4,787.32 (Mar 22) to 5,285.70, marking an increase of 498.38.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 3,346.52. This value is within the healthy range. It has increased from 2,903.32 (Mar 22) to 3,346.52, marking an increase of 443.20.
• For Enterprise Value (Cr.), as of Mar 23, the value is 1,543.39. It has decreased from 18,909.57 (Mar 22) to 1,543.39, marking a decrease of 17,366.18.
• For EV / Net Operating Revenue (X), as of Mar 23, the value is 0.20. This value is below the healthy minimum of 1. It has decreased from 3.77 (Mar 22) to 0.20, marking a decrease of 3.57.
• For EV / EBITDA (X), as of Mar 23, the value is 0.71. This value is below the healthy minimum of 5. It has decreased from 12.57 (Mar 22) to 0.71, marking a decrease of 11.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 0.39. This value is below the healthy minimum of 1. It has decreased from 3.92 (Mar 22) to 0.39, marking a decrease of 3.53.
• For Retention Ratios (%), as of Mar 23, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 99.42 (Mar 22) to 0.00, marking a decrease of 99.42.
• For Price / BV (X), as of Mar 23, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 3.71 (Mar 22) to 0.42, marking a decrease of 3.29.
• For Price / Net Operating Revenue (X), as of Mar 23, the value is 0.39. This value is below the healthy minimum of 1. It has decreased from 3.92 (Mar 22) to 0.39, marking a decrease of 3.53.
• For EarningsYield, as of Mar 23, the value is 0.46. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 22) to 0.46, marking an increase of 0.42.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness